Literature DB >> 8348267

Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.

P Macchioni1, L Boiardi, C Salvarani, F Rossi, M Casadei-Maldini, R Mancini, E Beltrandi, I Portioli.   

Abstract

The phenotypic characteristics of peripheral blood lymphocytes were investigated in 22 patients suffering from active polymyalgia rheumatica/giant cell arteritis (PMR/GCA) prior to steroid treatment. We observed a significant reduction in the absolute number and the relative percentage of CD4-, CD8+ and CD3+, CD16+ and/or CD56+ cells compared to controls. Fifteen patients were investigated prospectively over a 6-month period of prednisone therapy. At the end of the study CD4-CD8+ cells had increased significantly compared to baselines, CD3+ CD16+ and/or CD56+ cells remained significantly lower when compared to controls. We did not observe any abnormalities in the absolute number and percentage of HLA-DR+ T lymphocytes, CD5+ B cells and NK cell phenotypes before or during steroid treatment. Our study confirms that there was significant increase in the absolute number of CD8+ T cells during steroid treatment in the PMR/GCA patients, but indicates the persistence of an immunological alteration despite the control of disease manifestations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348267     DOI: 10.1093/rheumatology/32.8.666

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

1.  Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

Authors:  A Uddhammar; G Roos; B Näsman; S R Dahlqvist
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

2.  The Cambridge dilemma.

Authors:  P Elling; H Elling; A T Olsson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

Review 3.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

4.  Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Authors:  Sebastiano Cicco; Vanessa Desantis; Antonio Vacca; Gerardo Cazzato; Antonio G Solimando; Anna Cirulli; Silvia Noviello; Cecilia Susca; Marcella Prete; Gabriele Brosolo; Cristiana Catena; Aurelia Lamanuzzi; Ilaria Saltarella; Maria Antonia Frassanito; Antonella Cimmino; Giuseppe Ingravallo; Leonardo Resta; Roberto Ria; Monica Montagnani
Journal:  Front Med (Lausanne)       Date:  2022-05-16

5.  Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.

Authors:  C Salvarani; L Boiardi; P Macchioni; F Rossi; P Tartoni; M Casadei Maldini; R Mancini; E Beltrandi; I Portioli
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 6.  CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?

Authors:  Rosanne D Reitsema; Annemieke M H Boots; Kornelis S M van der Geest; Maria Sandovici; Peter Heeringa; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

7.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

8.  Complete blood count reflecting the disease status of giant cell arteritis: A retrospective study of Chinese patients.

Authors:  Yue Yin; Yun Zhang; Dongmei Wang; Xinxin Han; Xiaotian Chu; Min Shen; Xuejun Zeng
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.